Warren Thomas Brown
Keine laufenden Positionen mehr
Karriereverlauf von Warren Thomas Brown
Ehemalige bekannte Positionen von Warren Thomas Brown
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| INVION LIMITED | Direktor/Vorstandsmitglied | 04.11.2011 | 22.03.2018 |
| Independent Dir/Board Member | 04.11.2011 | 22.03.2018 | |
CBio Ltd.
 CBio Ltd. BiotechnologyHealth Technology CBio Ltd. focuses on developing new generation products for the treatment of autoimmune and inflammatory diseases. It develops and commercializes treatments for autoimmune diseases. The company focuses and develops technologies on commercializing its proprietary drug, XToll for autoimmune and inflammatory diseases. It develops technologies for the treatment of autoimmune and inflammatory diseases. The company also engages in the business of research, product development and clinical trials of the therapeutic drug XToll and development of variants to the company's Cpn10 technology. CBio was founded by Steve P. Jones on October 11, 2000 and is headquartered at Brisbane, Australia. | Direktor/Vorstandsmitglied | 04.11.2011 | 29.11.2011 |
| MESA MINERALS LIMITED | Direktor/Vorstandsmitglied | 22.06.2010 | 22.06.2010 |
Statistik
International
| Australien | 4 |
Operativ
| Director/Board Member | 3 |
| Independent Dir/Board Member | 1 |
Sektoral
| Health Technology | 3 |
| Non-Energy Minerals | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| INVION LIMITED | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Mesa Minerals Ltd.
 Mesa Minerals Ltd. Other Metals/MineralsNon-Energy Minerals Mesa Minerals Ltd. engages in hydrometallurgical process technology. Its products includes electrolytic manganese dioxide, electrolytic manganese metal, micro nutrient, granulated manganese sulfate, and manganese ore. The company was founded on October 26, 1984 and is headquartered in Applecross, Australia. | Non-Energy Minerals |
CBio Ltd.
CBio Ltd. BiotechnologyHealth Technology CBio Ltd. focuses on developing new generation products for the treatment of autoimmune and inflammatory diseases. It develops and commercializes treatments for autoimmune diseases. The company focuses and develops technologies on commercializing its proprietary drug, XToll for autoimmune and inflammatory diseases. It develops technologies for the treatment of autoimmune and inflammatory diseases. The company also engages in the business of research, product development and clinical trials of the therapeutic drug XToll and development of variants to the company's Cpn10 technology. CBio was founded by Steve P. Jones on October 11, 2000 and is headquartered at Brisbane, Australia. | Health Technology |
- Börse
- Insiders
- Warren Thomas Brown
- Erfahrung
